Velcheti V - Search Results

1

Neuroendocrine lineage commitment of small cell lung cancers can be leveraged into p53-independent non-cytotoxic therapy.

Biswas S, Kang K, Ng KP, Radivoyevitch T, Schalper K, Zhang H, Lindner DJ, Thomas A, MacPherson D, Gastman B, Schrump DS, Wong KK, Velcheti V, Saunthararajah Y. Biswas S, et al. Among authors: velcheti v. Cell Rep. 2023 Aug 29;42(8):113016. doi: 10.1016/j.celrep.2023.113016. Epub 2023 Aug 18. Cell Rep. 2023. PMID: 37597186 Free PMC article.

2

Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors.

Margolin K, Morishima C, Velcheti V, Miller JS, Lee SM, Silk AW, Holtan SG, Lacroix AM, Fling SP, Kaiser JC, Egan JO, Jones M, Rhode PR, Rock AD, Cheever MA, Wong HC, Ernstoff MS. Margolin K, et al. Among authors: velcheti v. Clin Cancer Res. 2018 Nov 15;24(22):5552-5561. doi: 10.1158/1078-0432.CCR-18-0945. Epub 2018 Jul 25. Clin Cancer Res. 2018. PMID: 30045932 Free PMC article. Clinical Trial.

3

Efficacy of vinorelbine in the second-line setting and beyond in non-small cell lung cancer.

Subramanian J, Velcheti V, Baggstrom MQ, Govindan R. Subramanian J, et al. Among authors: velcheti v. J Thorac Oncol. 2007 Apr;2(4):373. doi: 10.1097/01.JTO.0000263727.74265.26. J Thorac Oncol. 2007. PMID: 17409816 Free article. No abstract available.

4

Absence of mutations in the epidermal growth factor receptor (EGFR) kinase domain in patients with mesothelioma.

Velcheti V, Kasai Y, Viswanathan AK, Ritter J, Govindan R. Velcheti V, et al. J Thorac Oncol. 2009 Apr;4(4):559. doi: 10.1097/JTO.0b013e31819c8661. J Thorac Oncol. 2009. PMID: 19333077 Free article. No abstract available.

5

Cost Effectiveness of Pembrolizumab vs. Standard-of-Care Chemotherapy as First-Line Treatment for Metastatic NSCLC that Expresses High Levels of PD-L1 in the United States.

Huang M, Lou Y, Pellissier J, Burke T, Liu FX, Xu R, Velcheti V. Huang M, et al. Among authors: velcheti v. Pharmacoeconomics. 2017 Aug;35(8):831-844. doi: 10.1007/s40273-017-0527-z. Pharmacoeconomics. 2017. PMID: 28620848 Free PMC article.

6

Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimen.

Velcheti V, Govindan R. Velcheti V, et al. Lung Cancer. 2007 Aug;57(2):240-2. doi: 10.1016/j.lungcan.2007.02.010. Epub 2007 Apr 2. Lung Cancer. 2007. PMID: 17400329

7

Metastatic cancer involving bladder: a review.

Velcheti V, Govindan R. Velcheti V, et al. Can J Urol. 2007 Feb;14(1):3443-8. Can J Urol. 2007. PMID: 17324324 Review.

8

First-line pembrolizumab monotherapy for metastatic PD-L1-positive NSCLC: real-world analysis of time on treatment.

Velcheti V, Chandwani S, Chen X, Pietanza MC, Burke T. Velcheti V, et al. Immunotherapy. 2019 Jul;11(10):889-901. doi: 10.2217/imt-2019-0061. Epub 2019 Jun 11. Immunotherapy. 2019. PMID: 31181973 Free article. Clinical Trial.

9

Vaginal masses: magnetic resonance imaging features with pathologic correlation.

Elsayes KM, Narra VR, Dillman JR, Velcheti V, Hameed O, Tongdee R, Menias CO. Elsayes KM, et al. Among authors: velcheti v. Acta Radiol. 2007 Oct;48(8):921-33. doi: 10.1080/02841850701552926. Acta Radiol. 2007. PMID: 17924224 Review.

10

Hedgehog signaling pathway and lung cancer.

Velcheti V, Govindan R. Velcheti V, et al. J Thorac Oncol. 2007 Jan;2(1):7-10. doi: 10.1097/JTO.0b013e31802c0276. J Thorac Oncol. 2007. PMID: 17410003 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

164 results

Search Page

Filters